Validation of High-Risk Computed Tomography Features for Detection of Local Recurrence After Stereotactic Body Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer

International Journal of Radiation Oncology Biology Physics

Volumn 96, Issue 1, 2016, Pages 134-141

  Peulen, Heike ^a   Mantel, Frederick ^b,c   Guckenberger, Matthias ^b   Belderbos, José ^a   Werner Wasik, Maria ^d   Hope, Andrew ^e   Giuliani, Meredith ^e   Grills, Inga ^f   Sonke, Jan Jakob ^a  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

^b UNIVERSITY OF WÜRZBURG   (Germany)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^d THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

^e UNIVERSITY OF TORONTO   (Canada)

^f Department of Radiation Oncology Beaumont Hospital ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL ORGANS; DISEASES; FEATURE EXTRACTION; OPACITY; PATIENT TREATMENT; RADIOTHERAPY; TOMOGRAPHY;

AREA UNDER THE CURVES; CONFIDENCE INTERVAL; METHODS AND MATERIALS; NON SMALL CELL LUNG CANCER; PLANNING TARGET VOLUMES; RECEIVER OPERATING CHARACTERISTIC ANALYSIS; SENSITIVITY AND SPECIFICITY; STEREOTACTIC BODY RADIATION THERAPY;

COMPUTERIZED TOMOGRAPHY;

ADULT; AGED; ARTICLE; BRONCHOGRAPHY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CLINICAL ARTICLE; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EARLY CANCER; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HUMAN; LUNG LOBE; MALE; MULTICENTER STUDY; NON SMALL CELL LUNG CANCER; PLEURA EFFUSION; PRIORITY JOURNAL; RADIOLOGICAL PARAMETERS; STEREOTACTIC BODY RADIATION THERAPY; VALIDATION STUDY; VERY ELDERLY; CARCINOMA, NON-SMALL-CELL LUNG; CLINICAL TRIAL; DIAGNOSTIC IMAGING; DIFFERENTIAL DIAGNOSIS; EVALUATION STUDY; INTERNATIONAL COOPERATION; LUNG NEOPLASMS; MIDDLE AGED; PATHOLOGY; PREVENTION AND CONTROL; PROCEDURES; RADIOSURGERY; REPRODUCIBILITY; RETROSPECTIVE STUDY; RISK FACTOR; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME; TUMOR RECURRENCE; X-RAY COMPUTED TOMOGRAPHY;

AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; INTERNATIONALITY; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; RADIOSURGERY; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; RISK FACTORS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 84990822036     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2016.04.003     Document Type: Article

References (37)

1. 1 Siegel, R.L., Miller, K.D., Jemal, A., Cancer statistics, 2015. CA Cancer J Clin 65 (2015), 5–29.
2. 2 Christensen, J.D., Chiles, C., Low-dose computed tomographic screening for lung cancer. Clin Chest Med 36 (2015), 147–160 vii.
3. 3 International Early Lung Cancer Action Program Investigators, Henschke, C.I., Yankelevitz, D.F., Libby, D.M., et al. Survival of patients with stage I lung cancer detected on CT screening. N Engl J Med 355 (2006), 1763–1771.
4. 4 Palma, D., Visser, O., Lagerwaard, F.J., et al. Impact of introducing stereotactic lung radiotherapy for elderly patients with stage I non-small-cell lung cancer: A population-based time-trend analysis. J Clin Oncol 28 (2010), 5153–5159.
5. 5 Baumann, P., Nyman, J., Hoyer, M., et al. Outcome in a prospective phase II trial of medically inoperable stage I non-small-cell lung cancer patients treated with stereotactic body radiotherapy. J Clin Oncol 27 (2009), 3290–3296.
6. 6 Bral, S., Gevaert, T., Linthout, N., et al. Prospective, risk-adapted strategy of stereotactic body radiotherapy for early-stage non-small-cell lung cancer: Results of a phase II trial. Int J Radiat Oncol Biol Phys 80 (2011), 1343–1349.
7. 7 Ricardi, U., Filippi, A.R., Guarneri, A., et al. Stereotactic body radiation therapy for early stage non-small cell lung cancer: Results of a prospective trial. Lung Cancer 68 (2010), 72–77.
8. 8 Timmerman, R., Paulus, R., Galvin, J., et al. Stereotactic body radiation therapy for inoperable early stage lung cancer. JAMA 303 (2010), 1070–1076.
9. 9 Chang, J.Y., Senan, S., Paul, M.A., et al. Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: A pooled analysis of two randomised trials. Lancet Oncol 16 (2015), 630–637.
10. 10 Allibhai, Z., Cho, B.C., Taremi, M., et al. Surgical salvage following stereotactic body radiotherapy for early-stage NSCLC. Eur Respir J 39 (2012), 1039–1042.
11. 11 Chen, F., Matsuo, Y., Yoshizawa, A., et al. Salvage lung resection for non-small cell lung cancer after stereotactic body radiotherapy in initially operable patients. J Thorac Oncol 5 (2010), 1999–2002.
12. 12 Neri, S., Takahashi, Y., Terashi, T., et al. Surgical treatment of local recurrence after stereotactic body radiotherapy for primary and metastatic lung cancers. J Thorac Oncol 5 (2010), 2003–2007.
13. 13 Peulen, H., Karlsson, K., Lindberg, K., et al. Toxicity after reirradiation of pulmonary tumours with stereotactic body radiotherapy. Radiother Oncol 101 (2011), 260–266.
14. 14 Dahele, M., Palma, D., Lagerwaard, F., et al. Radiological changes after stereotactic radiotherapy for stage I lung cancer. J Thorac Oncol 6 (2011), 1221–1228.
15. 15 Guckenberger, M., Heilman, K., Wulf, J., et al. Pulmonary injury and tumor response after stereotactic body radiotherapy (SBRT): Results of a serial follow-up CT study. Radiother Oncol 85 (2007), 435–442.
16. 16 Trovo, M., Linda, A., El Naqa, I., et al. Early and late lung radiographic injury following stereotactic body radiation therapy (SBRT). Lung Cancer 69 (2010), 77–85.
17. 17 Taira, N., Kawabata, T., Ichi, T., et al. Salvage operation for late recurrence after stereotactic body radiotherapy for lung cancer: Two patients with no viable cancer cells. Ann Thorac Surg 97 (2014), 2167–2171.
18. 18 Kato, S., Nambu, A., Onishi, H., et al. Computed tomography appearances of local recurrence after stereotactic body radiation therapy for stage I non-small-cell lung carcinoma. Jpn J Radiol 28 (2010), 259–265.
19. 19 Matsuo, Y., Nagata, Y., Mizowaki, T., et al. Evaluation of mass-like consolidation after stereotactic body radiation therapy for lung tumors. Int J Clin Oncol 12 (2007), 356–362.
20. 20 Takeda, A., Kunieda, E., Takeda, T., et al. Possible misinterpretation of demarcated solid patterns of radiation fibrosis on CT scans as tumor recurrence in patients receiving hypofractionated stereotactic radiotherapy for lung cancer. Int J Radiat Oncol Biol Phys 70 (2008), 1057–1065.
21. 21 Huang, K., Dahele, M., Senan, S., et al. Radiographic changes after lung stereotactic ablative radiotherapy (SABR): Can we distinguish recurrence from fibrosis? A systematic review of the literature. Radiother Oncol 102 (2012), 335–342.
22. 22 Huang, K., Senthi, S., Palma, D.A., et al. High-risk CT features for detection of local recurrence after stereotactic ablative radiotherapy for lung cancer. Radiother Oncol 109 (2013), 51–57.
23. 23 Grills, I.S., Hope, A.J., Guckenberger, M., et al. A collaborative analysis of stereotactic lung radiotherapy outcomes for early-stage non-small-cell lung cancer using daily online cone-beam computed tomography image-guided radiotherapy. J Thorac Oncol 7 (2012), 1382–1393.
24. 24 Kestin, L., Grills, I., Guckenberger, M., et al. Dose-response relationship with clinical outcome for lung stereotactic body radiotherapy (SBRT) delivered via online image guidance. Radiother Oncol 110 (2014), 499–504.
25. 25 Eisenhauer, E.A., Therasse, P., Bogaerts, J., et al. New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1). Eur J Cancer 45 (2009), 228–247.
26. 26 Guckenberger, M., Krieger, T., Richter, A., et al. Potential of image-guidance, gating and real-time tracking to improve accuracy in pulmonary stereotactic body radiotherapy. Radiother Oncol 91 (2009), 288–295.
27. 27 Karlsson, K., Nyman, J., Baumann, P., et al. Retrospective cohort study of bronchial doses and radiation-induced atelectasis after stereotactic body radiation therapy of lung tumors located close to the bronchial tree. Int J Radiat Oncol Biol Phys 87 (2013), 590–595.
28. 28 Senthi, S., Ullmann, E.F., Senan, S., Pulmonary atelectasis after stereotactic ablative radiotherapy for a central lung tumor. J Thorac Oncol 8 (2013), e94–e95.
29. 29 Dunlap, N.E., Yang, W., McIntosh, A., et al. Computed tomography-based anatomic assessment overestimates local tumor recurrence in patients with mass-like consolidation after stereotactic body radiotherapy for early-stage non-small cell lung cancer. Int J Radiat Oncol Biol Phys 84 (2012), 1071–1077.
30. 30 Faruqi, S., Giuliani, M.E., Raziee, H., et al. Interrater reliability of the categorization of late radiographic changes after lung stereotactic body radiation therapy. Int J Radiat Oncol Biol Phys 89 (2014), 1076–1083.
31. 31 Nakajima, N., Sugawara, Y., Kataoka, M., et al. Differentiation of tumor recurrence from radiation-induced pulmonary fibrosis after stereotactic ablative radiotherapy for lung cancer: Characterization of 18F-FDG PET/CT findings. Ann Nucl Med 27 (2013), 261–270.
32. 32 MacManus, M., Everitt, S., Hicks, R.J., The evolving role of molecular imaging in non-small cell lung cancer radiotherapy. Semin Radiat Oncol 25 (2015), 133–142.
33. 33 Chen, X., Qin, L., Pan, D., et al. Liver diffusion-weighted MR imaging: Reproducibility comparison of ADC measurements obtained with multiple breath-hold, free-breathing, respiratory-triggered, and navigator-triggered techniques. Radiology 271 (2014), 113–125.
34. 34 Mattonen, S.A., Palma, D.A., Haasbeek, C.J., et al. Distinguishing radiation fibrosis from tumour recurrence after stereotactic ablative radiotherapy (SABR) for lung cancer: A quantitative analysis of CT density changes. Acta Oncol 52 (2013), 910–918.
35. 35 Mattonen, S.A., Palma, D.A., Haasbeek, C.J., et al. Early prediction of tumor recurrence based on CT texture changes after stereotactic ablative radiotherapy (SABR) for lung cancer. Med Phys, 41, 2014, 033502.
36. 36 Aerts, H.J., Velazquez, E.R., Leijenaar, R.T., et al. Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach. Nat Commun, 5, 2014, 4006.
37. 37 Mattonen, S.A., Palma, D.A., Johnson, C., et al. Detection of local recurrence after stereotactic ablative radiotherapy (SABR) for lung cancer: Physician performance versus radiomic assessment. Int J Radiat Oncol Biol Phys 94 (2016), 1121–1128.